Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20501 - 20525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Curcumin	Approved Investigational	MPHOSPH6	10200	downregulated	Curcumin results in decreased expression of MPHOSPH6 mRNA	16q23.3	A21795
Curcumin	Approved Investigational	MRPL1	65008	upregulated	Curcumin results in increased expression of MRPL1 mRNA	4q21.1	A21786
Curcumin	Approved Investigational	MS4A1	931	downregulated	Curcumin results in decreased expression of MS4A1 mRNA	11q12.2	A21786
Curcumin	Approved Investigational	MS4A1	931	upregulated	Curcumin results in increased expression of MS4A1 mRNA	11q12.2	A21795
Curcumin	Approved Investigational	MST1R	4486	downregulated	Curcumin results in decreased expression of MST1R mRNA	3p21.31	A21849
Curcumin	Approved Investigational	MTOR	2475	downregulated	Curcumin analog results in decreased expression of MTOR mRNA	1p36.22	A21790
Curcumin	Approved Investigational	MVD	4597	downregulated	Curcumin results in decreased expression of MVD mRNA	16q24.2	A21786
Curcumin	Approved Investigational	MXD1	4084	upregulated	Curcumin results in increased expression of MXD1 mRNA	2p13.3	A21794
Curcumin	Approved Investigational	MXD3	83463	downregulated	Curcumin results in decreased expression of MXD3 mRNA	5q35.3	A21794 A21786
Curcumin	Approved Investigational	MYC	4609	downregulated	Curcumin results in decreased expression of MYC mRNA	8q24.21	A21807
Curcumin	Approved Investigational	MYC	4609	upregulated	Curcumin results in increased expression of MYC mRNA	8q24.21	A21794
Curcumin	Approved Investigational	MYL12A	10627	upregulated	Curcumin results in increased expression of MYL12A mRNA	18p11.31	A21797
Curcumin	Approved Investigational	MYLK	4638	upregulated	Curcumin results in increased expression of MYLK mRNA	3q21.1	A21792
Curcumin	Approved Investigational	NAIP	4671	downregulated	Curcumin analog results in decreased expression of NAIP mRNA	5q13.2	A21803 A21804
Curcumin	Approved Investigational	NAIP	4671	downregulated	Curcumin results in decreased expression of NAIP mRNA	5q13.2	A21803 A21804
Curcumin	Approved Investigational	NANOS1	340719	downregulated	Curcumin results in decreased expression of NANOS1 mRNA	10q26.11	A21797
Curcumin	Approved Investigational	NFYA	4800	downregulated	Curcumin results in decreased expression of NFYA mRNA	6p21.1	A21794
Curcumin	Approved Investigational	NHLRC2	374354	downregulated	Curcumin results in decreased expression of NHLRC2 mRNA	10q25.3	A21797
Curcumin	Approved Investigational	NKX3-1	4824	downregulated	Curcumin results in decreased expression of NKX3-1 mRNA	8p21.2	A21850 A21799
Curcumin	Approved Investigational	NME1	4830	upregulated	Curcumin results in increased expression of NME1 mRNA	17q21.33	A21786
Curcumin	Approved Investigational	NOTCH1	4851	downregulated	Curcumin results in decreased expression of NOTCH1 mRNA	9q34.3	A21828
Curcumin	Approved Investigational	NPC2	10577	downregulated	Curcumin results in decreased expression of NPC2 mRNA	14q24.3	A21786
Curcumin	Approved Investigational	NQO1	1728	upregulated	Curcumin analog results in increased expression of NQO1 mRNA	16q22.1	A21832
Curcumin	Approved Investigational	NQO1	1728	upregulated	Curcumin results in increased expression of NQO1 mRNA	16q22.1	A21786 A21834 A21851 A21833 A21832
Curcumin	Approved Investigational	NR1H3	10062	upregulated	Curcumin results in increased expression of NR1H3 mRNA	11p11.2	A21791

Displaying entries 20501 - 20525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability